Tandem Diabetes Care | TNDM - 贷款资金



金融业
股票价格
USD
资产
USD 881.11M
现金及等价物
USD 90.63M
销售成本
USD 122.92M
流动资产
USD 618.14M
流动负债
USD 242.72M
债务
USD 449.28M
EBIT
USD 8.29M
EBITDA
USD 32.9M
员工
2.65K
EPS每股收益
USD -0.01
股本和储备
USD 155.17M
销售毛利
USD 167.46M
债务利息支出
USD 2.08M
利息收入
USD 2.51M
贷款资金
USD 310.04M
市值
USD 1.57B
净收入
USD -589K
营业费用
USD 282.09M
营业利润
USD 8.29M
普通股股本
USD 68.29M
PE价格收益
681.05
税前利润
USD -25.14M
销售收入
USD 290.4M
销售和管理费用
USD 99.86M
股票
USD 128.77M
贸易债权人
USD 47.07M
应收帐款人
USD 165.49M


贷款资金 更改 日
Abbott USD 9.9B 1.7B 2025-12
Accuray USD 127.32M 3.53M 2025-09
Align Technology USD 0 0 2024-12
AtriCure USD 61.86M 0 2025-12
Baxter International USD 9.47B 726M 2025-12
Becton, Dickinson and Co. USD 16.92B 705M 2025-12
Boston Scientific USD 10.99B 12M 2025-09
Cooper Companies USD 1.88B 578.5M 2025-12
Dexcom USD 1.24B 53.6M 2025-12
Edwards Lifesciences USD 598.2M 200K 2025-09
Eli Lilly USD 40.87B 5.6M 2025-12
Globus Medical USD 436K 9K 2025-12
ICU Medical USD 1.27B 48.01M 2025-12
Inogen USD 0 0 2022-06
Insulet USD 930.8M 4.1M 2025-12
Integra LifeSciences USD 1.86B 63.76M 2025-12
Intuitive Surgical USD 0 0 2025-03
J&J USD 39.44B 30M 2025-12
Masimo USD 518M 41.1M 2025-12
Medtronic USD 27.88B 255M 2025-12
Merit Medical Systems USD 734.04M 1.12M 2025-12
Orthofix International USD 174.45M 17.23M 2025-12
Roche Holding CHF 27.43B 966M 2025-12
Stryker USD 14.86B 14M 2025-12
Tandem Diabetes Care USD 310.04M 446K 2025-12
Teleflex USD 2.54B 30.06M 2025-12
Zimmer Biomet Holdings USD 6.93B 580.6M 2025-12